Current role
John Dal Poggetto
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Dal Poggetto
Sonoma Pharmaceuticals, Inc. reported in an 8-K filed July 14, 2023 that John Dal Poggetto was appointed Controller, effective July 17, 2023. The proxy statement of Sonoma Pharmaceuticals, Inc. reports total compensation of $284,186 for John Dal Poggetto in fiscal 2020, including a base salary of $204,183.
“Effective July 17, 2023, our Board of Directors appointed John Dal Poggetto as our Controller.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-07-17–present
-
2023-07-17–2020-04-24
-
Start not stated–2020-04-24
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sonoma Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Bubba Sandford CEO
- Chad White CFO
- Grant Edwards CFO
- Amy Trombly Board Member
- Jerry McLaughlin Board Member
- Ms. Vanessa Jacoby Board Member
- Philippe Weigerstorfer Board Member
- Vanessa Jacoby Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Sonoma Pharmaceuticals, Inc. (SNOA) | Former Chief Financial Officer | $204,183 | $284,186 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.